Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection

Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Surg
Autors principals: Nakamura, Kenichi, Beppu, Toru, Hayashi, Hiromitsu, Okabe, Hirohisa, Imai, Kastunori, Nitta, Hidetoshi, Chikamoto, Akira, Ishiko, Takatoshi, Sasaki, Masato, Baba, Hideo
Format: Artigo
Idioma:Inglês
Publicat: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Matèries:
Hepatobiliary & Pancreatic Surgery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/
https://ncbi.nlm.nih.gov/pubmed/26011214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars